Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1041 clinical trials
The Effect of The Personalized Patient Engagement Plan on Diabetes Management

This study evaluates the effect of Personalized Patient Engagement Plan on diabetes management in patients with at least six months of Type-2 Diabetes. The research is planned to be carried out as an experimental study with pretest-posttest control groups. Half of the participants will receive the Personalized Patient Engagement Plan; …

antidiabetic agents
antidiabetic agent
  • 0 views
  • 19 Feb, 2024
Study on the Ability of Virtual Reality Glasses in Anxiety and Pain Reduction in 50 Women Undergoing Amniocentesis or Feticide

Both amniocenteses and especially feticide are procedures that incorporate both anxiety and pain. As anxiety and pain can be reduced when using a distraction, The investigators speculate that the use of virtual reality glasses during these procedures will elevate both anxiety and pain.

  • 0 views
  • 19 Feb, 2024
Turkish of the SARS-CoV-2 Anxiety Scale

The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determining the anxiety levels of individuals in the society and supporting them psychologically is of great importance.

SARS
acute respiratory syndrome (sars)
coronavirus
coronavirus infection
anxiety
  • 0 views
  • 19 Feb, 2024
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD

Therefore, it is vitally essential to contemplate the supplementation with amino acids that prevent and delay the loss of protein reserves, as well as the delay in clinical status. The -hydroxy--methyl butyrate (HMB) is a metabolite of leucine, with an anticatabolic and anabolic effect.

leucine
pulmonary disease
cardiovascular disease
bronchodilator
pulmonary rehabilitation
  • 0 views
  • 19 Feb, 2024
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).

refractory acute myeloid leukemia (aml)
myelodysplastic syndrome
exhaustion
exhausted
cancer therapy
  • 0 views
  • 19 Feb, 2024
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Nivolumab (anti-PD1) has been approved for patients progressing on or after platinum-based therapy, as it clearly impacts on overall survival. This randomized phase II study will evaluate the efficacy of nivolumab plus paclitaxel for first-line treatment of recurrent or metastatic HNSCC in the platinum ineligible and platinum refractory settings.

renal impairment
cisplatin
platelet count
neck cancer
heart disease
  • 0 views
  • 19 Feb, 2024
An N-of-1 Trial of an Internet-delivered CBT Program Based on the Psychological Flexibility Model of Chronic Pain for Cancer-related Difficulties

</p><p>The investigators will pilot test the modified treatment program in N-of-1 Trials that permit to estimate both between and within subject treatment effects, as well as processes that explain treatment outcome at the individual level, with a high degree of confidence.</p>

  • 0 views
  • 15 Jan, 2025
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions  

Possible significant differences in cytokine levels will reveal that these proteins and enzymes can be utilized as a diagnostic tool in periodontal diseases, to distinguish periodontal disease status from healthy, or as a guide for treatments.

  • 0 views
  • 08 May, 2025
AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive Metastatic NSCLC

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, improves outcome when compared to a platinum chemotherapy-based regimen chosen by the Investigator from a list of standard of care treatments, as measured primarily by progression free survival (PFS), for …

lung cancer
platinum-based chemotherapy
cisplatin
carcinoma
progressive disease
  • 0 views
  • 19 Feb, 2024
The Alberta NutrIMM Study - Nutrition and Immunity

Results of the study will be compared to results of the control group (which will go through the same activities as the experimental groups).

type 2 diabetes mellitus
diabetes
hyperglycemia
lipoprotein cholesterol
heart disease
  • 0 views
  • 19 Feb, 2024